Icon (ICLR) Total Debt Growth (3y) (2012 - 2026)
Powered by 
Analysis
Icon (ICLR) Total Debt Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 5.11% |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | - |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | -7.70% |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | -0.73% |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | -13.07% |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | -1.66% |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | - |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | - |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | - |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -7.70% |
| Mar 31, 2026 | -8.88% |
| Dec 31, 2025 | -9.92% |
| Sep 30, 2025 | -11.09% |
| Jun 30, 2025 | -12.21% |
| Mar 31, 2025 | -12.71% |
| Dec 31, 2024 | -14.26% |
| Sep 30, 2024 | -16.65% |
| Jun 30, 2024 | 114.16% |
| Mar 31, 2024 | 190.57% |
| Dec 31, 2023 | 188.81% |
| Sep 30, 2022 | 140.30% |
| Jun 30, 2022 | 154.27% |
| Mar 31, 2022 | 145.07% |
| Dec 31, 2021 | 149.68% |
| Sep 30, 2021 | 103.99% |
| Dec 31, 2020 | -0.04% |
| Sep 30, 2019 | -4.51% |
| Jun 30, 2019 | -44.28% |
| Mar 31, 2019 | 0.10% |